Several issues accompanied by novel oral anticoagulants
スポンサーリンク
概要
- 論文の詳細を見る
Novel oral anticoagulants (NOAC), have appeared or are under development to overcome the limitation of warfarin, which has been widely used for more than 50 years in Japan. When compared to warfarin, NOAC are as effective or superior in the prevention of stroke, as same or lower in the frequency of major hemorrhagic complication, and much lower in the frequency of intracranial bleedings. Therefore, NOAC is superior to warfarin. However, several issues have been pointed out, such as, how to manage major hemorrhage, rt-PA thrombolysis in patients treated with NOAC, proper administration, and management around operation period. In this review, these several issues are discussed from the stand point of pharmacological properties of NOAC and previous reports.
- 一般社団法人 日本脳卒中学会の論文
一般社団法人 日本脳卒中学会 | 論文
- Two cases with aphasia in the left putaminal damage and one case with visuospatial neglect in the right putaminal damage
- Alterations of plasma von Willebrand factor activity and the influence of anti-platelet drugs in acute cerebral infarction
- Carotid endarterectomy plaques correlation of clinical events and morphology.
- Stenting for stenosis of major cerebrovascular arteries.
- Cerebral infarction following antihypertensive therapy.